These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 17879547

  • 21. [Electrophysiological changes in diabetic peripheral neuropathy patients of different Chinese medicine syndrome types intervened by naoxintong and mecobalamin].
    Huang PJ, Mao XH, Wang YP.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Aug; 31(8):1051-6. PubMed ID: 21910333
    [Abstract] [Full Text] [Related]

  • 22. Effects of Huangqi Guizhi Wuwu Tang on diabetic peripheral neuropathy.
    Tong Y, Hou H.
    J Altern Complement Med; 2006 Aug; 12(6):506-9. PubMed ID: 16884339
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Survey of current studies of effects of traditional Chinese medicine on nerve growth factor and diabetic peripheral neuropathy].
    Wu Q, Liang X.
    Zhongguo Zhong Yao Za Zhi; 2010 Jul; 35(14):1896-9. PubMed ID: 20939294
    [Abstract] [Full Text] [Related]

  • 26. [Nonenzymatically glycosylated proteins and diabetic neuropathy: current status of traditional Chinese medicine therapy].
    Zhang K, Liang X.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1998 Feb; 18(2):125-6. PubMed ID: 11367644
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Experiences in treating diabetic peripheral neuropathy with traditional Chinese medicine.
    WEI ZX.
    Chin J Integr Med; 2008 Dec; 14(4):248-50. PubMed ID: 19082794
    [No Abstract] [Full Text] [Related]

  • 30. Research progress of the effective active ingredients of Astragalus mongholicus in the treatment of diabetic peripheral neuropathy.
    Liu Y, Yu R, Wang X, Chen Y, Yin T, Gao Q, Sun L, Zheng Z.
    Biomed Pharmacother; 2024 Apr; 173():116350. PubMed ID: 38430632
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A Review on Mechanistic and Pharmacological Findings of Diabetic Peripheral Neuropathy including Pharmacotherapy.
    Tiwari R, Wal P, Singh P, Tiwari G, Rai A.
    Curr Diabetes Rev; 2021 Apr; 17(3):247-258. PubMed ID: 32928092
    [Abstract] [Full Text] [Related]

  • 35. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
    Obrosova IG, Van Huysen C, Fathallah L, Cao XC, Greene DA, Stevens MJ.
    FASEB J; 2002 Jan; 16(1):123-5. PubMed ID: 11709499
    [Abstract] [Full Text] [Related]

  • 36. Peripheral nerve dysfunction in experimental diabetes is mediated by cyclooxygenase-2 and oxidative stress.
    Kellogg AP, Pop-Busui R.
    Antioxid Redox Signal; 2005 Jan; 7(11-12):1521-9. PubMed ID: 16356116
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.